Phosphodiesterase 5 inhibitors and cystic fibrosis: correcting chloride channel dysfunction

Am J Respir Crit Care Med. 2008 Mar 1;177(5):469-70. doi: 10.1164/rccm.200712-1805ED.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Animals
  • Chlorides / metabolism*
  • Cystic Fibrosis Transmembrane Conductance Regulator / metabolism
  • Disease Models, Animal
  • Imidazoles / pharmacokinetics*
  • Membrane Potentials / drug effects*
  • Mice
  • Mice, Inbred CFTR
  • Phosphodiesterase 5 Inhibitors*
  • Phosphodiesterase Inhibitors / pharmacokinetics*
  • Piperazines / pharmacokinetics*
  • Protein Modification, Translational / drug effects
  • Purines / pharmacokinetics
  • Sildenafil Citrate
  • Sulfones / pharmacokinetics*
  • Triazines / pharmacokinetics
  • Vardenafil Dihydrochloride

Substances

  • Chlorides
  • Imidazoles
  • Phosphodiesterase 5 Inhibitors
  • Phosphodiesterase Inhibitors
  • Piperazines
  • Purines
  • Sulfones
  • Triazines
  • Cystic Fibrosis Transmembrane Conductance Regulator
  • Vardenafil Dihydrochloride
  • Sildenafil Citrate